Epidemiology of chronic obstructive pulmonary disease;L'epidemiologia della broncopneumopatia cronica ostruttiva

Annali dell'Istituto Superiore di Sanita

Volumn 39, Issue 4, 2003, Pages 467-484

  Scognamiglio, Antonio ^a   Matteelli, Gabriella ^b   Pistelli, Francesco ^b   Baldacci, Sandra ^a   Carrozzi, Laura ^b   Viegi, Giovanni ^a  

^a CNR   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Air pollution; Chronic obstructive pulmonary disease; Epidemiology; General population; Morbidity; Mortality; Tobacco smoking

Indexed keywords

TOBACCO SMOKE;

AIR POLLUTION; CAUSE OF DEATH; CHILDHOOD DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIET; EARLY DIAGNOSIS; ENVIRONMENTAL FACTOR; FAMILY HISTORY; GENETIC SUSCEPTIBILITY; HEALTH CARE PERSONNEL; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MORBIDITY; MORTALITY; REVIEW; SOCIAL STATUS;

ADULT; AIR POLLUTION; COSTS AND COST ANALYSIS; DIET; HUMANS; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 1842480993     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (137)

1. Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, Yernault JC, Decramer M, Higenbottam T, Postma DS on behalf of the European Respiratory Society Task Force. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995;8:1398-420.
2. Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, Ligabue G, Ciaccia A, Saetta M, Papi A. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:418-24.
3. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:77S-121S.
4. World Health Organization. Manual of the international statistical classification of diseases, injuries and causes of death. vol. I, 9th revision. Geneva: WHO; 1977.
5. World Health Organization. International statistical classification of diseases and related health problems. 10th revision. Geneva: WHO; 1992.
6. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020. Lancet 1997;349:1498-504.
7. Gulsvik A. Mortality in and prevalence of chronic obstructive pulmonary disease in different parts of Europe. Monaldi Arch Chest Dis 1999;54:160-2.
8. Hurd SS. International efforts directed at attacking the problem of COPD. Chest 2000;117:336s-8s.
9. Pride NB, Soriano JB. Chronic obstructive pulmonary disease in the United Kingdom: trends in mortality, morbidity, and smoking. Curr Opin Pulm Med 2002;8:95-101.
10. Istituto Superiore di Sanità. La mortalità per causa in Italia: 1980-1998. Disponibile all'indirizzo: www.mortalita.iss.it/.
11. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveillance Summaries 2002;51:1-16.
12. Camilli AE, Robbins DR, Lebowitz MD. Death certificate reporting of confirmed airways obstructive disease. Am J Epidemiol 1991;133:795-800.
13. Izumi T. Chronic obstructive pulmonary disease in Japan. Curr Opin Pulm Med 2002;8:102-5.
14. Vestbo J, Prescott E, Lange P, Schnohr P, Jensen G. Vital prognosis after hospitalization for COPD: a study of a random population sample. Respir Med 1998;92:772-6.
15. Prescott E, Lange P, Vestbo J. Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur Respir J 1995;8:1333-8.
16. Istituto Nazionale di Statistica. Indagine multiscopo sulle famiglie "Condizioni di salute della popolazione" 1999-2000. Roma: ISTAT.
17. Ministero della Salute. Ricoveri Ospedalieri-Anno 2000. Disponibile all'indirizzo: www.ministerosalute.it.
18. Feenstra TL, van Genugten ML, Hoogenveen RT, Wouters EF, Rutten-van Molken MP. The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. Am J Respir Crit Care Med 2001;164:590-6.
19. Viegi G, Pedreschi M, Baldacci S, Chiaffi L, Pistelli F, Modena P, Vellutini M, Di Pede F, Carrozzi L. Prevalence rates of respiratory symptoms and diseases in general population samples of North and Central Italy. Int J Tuberc Lung Dis 1999;3:1034-42.
20. CIBA Foundation Guest Symposium. Terminology, definitions and classification of chronic pulmonary emphysema and related conditions. Thorax 1959;14:286-99.
21. Viegi G, Paoletti P, Carrozzi L, Vellutini M, Diviggiano E, Di Pede F, Pistelli G, Giuntini C, Lebowitz MD. Prevalence rates of respiratory symptoms in Italian general population samples, exposed to different levels of air pollution. Environ Health Perspect 1991;94:95-9.
22. Lundback B, Nystrom L, Rosenhall L, Stjernberg N. Obstructive lung disease in northern Sweden: respiratory symptoms assessed in a postal survey. Eur Respir J 1991;4:257-66.
23. Stang P, Lydick E, Silberman C, Kempel A, Keating ET. The prevalence of COPD: using smoking rates to estimate disease frequency in the general population. Chest 2000;117:354s-9s.
24. Lindstrom M, Jonsson E, Larsson K, Lundback B. Underdiagnosis of chronic obstructive pulmonary disease in Northern Sweden. Int J Tuberc Lung Dis 2002;6:76-84.
25. Pallasaho P, Lundback B, Meren M, Kiviloog J, Loit HM, Larsson K, Laitinen LA. Prevalence and risk factors for asthma and chronic bronchitis in the capitals Helsinki, Stockholm, and Tallinn. Respir Med 2002;96:759-69.
26. Huchon GJ, Vergnenegre A, Neukirch F, Brami G, Roche N, Preux PM. Chronic bronchitis among French adults: high prevalence and underdiagnosis. Eur Respir J 2002;20:806-12.
27. Viegi G, Pedreschi M, Pistelli F, Di Pede F, Baldacci S, Carrozzi L, Giuntini C. Prevalence of airway obstruction in a general population sample. European Respiratory Society vs American Thoracic Society definition. Chest 2000;117:339s-45s.
28. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-76.
29. American Thoracic Society. Evaluation of impairment/disability secondary to respiratory disorders. Am Rev Respir Dis 1986;133:1205-9.
30. Vestbo J, Lange P. Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 2002;166:329-32.
31. Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS, Morkve O. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002;20:1117-22.
32. van den Boom G, van Schayck CP, van Mollen MP, Tirimanna PR, den Otter JJ, van Grunsven PM, Buitendijk MJ, van Herwaarden CL, van Weel C. Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA program. Am J Respir Crit Care Med 1998;158:1730-8.
33. Zielinski J, Bednarek M. Know the age of your lung study group. Early detection of COPD in a high-risk population using spirometric screening. Chest 2001;119:731-6.
34. Czajkowska-Malinowska M, Nowinski A, Gorecka D, Zielinski J. Effects of spirometric screening in the community on smoking cessation. Pneumonol Alergol Pol 2001;69:524-9
35. Cerveri I, Accordini S, Verlato G, Corsico A, Zoia MC, Casali L, Burney P, de Marco R. European Community Respiratory Health Survey (ECRHS) Study Group. Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults. Eur Respir J 2001;18:85-92.
36. Luisetti M, Medaglia S, Tamburnotti C, Zorzetto M. Predisposizione genetica alle BPCO. In: Il volto della BPCO che cambia. vol. 1. Giuntini C, Grassi G (Ed.). Torino: UTET; 2001. p. 69-80.
37. Viegi G, Scognamiglio A, Baldacci S, Pistelli F, Carrozzi L. Epidemiology of chronic obstructive pulmonary disease (COPD). Respiration 2001;68:4-19.
38. Foos L, Parè PD, Sandford AF. Genetic risk factors for chronic obstructive pulmonary disease. Swiss Medical Wkly 2002;132: 27-37.
39. Lundback B, Lindberg A, Lindstrom A, Ronmark E, Jonsson AC, Jonsson E, Larsson LG, Andersson S, Sandstrom T, Larsson K. Obstructive Lung Disease in Northern Sweden Studies. Not 15 but 50% of smokers develop COPD? Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003;97:115-22.
40. Matteelli G, Scognamiglio A, Pistelli F, Baldacci S, Carrozzi L, Viegi G. L'epidemiologia della broncopneumopatia cronica ostruttiva. Minerva Pneumol 2003;42:67-84.
41. Chen Y, Breithaupt K, Muhajarine N. Occurrence of chronic obstructive pulmonary disease among Canadians and sex-related risk factors. J Clin Epidem 2000;53:755-61.
42. Bone CR, Higgins MW, Hurs SS, Reynolds HY. Research needs and opportunities related to respiratory health of women. Am Rev Respir Dis 1992;146:528-35.
43. Prescott E, Bjerg AM, Andersen PK, Lange P, Vestbo J. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J 1997;10:822-7.
44. Doll R. Risk from tobacco and potentials for health gain. Int J Tuberc Lung Dis 1999;3:90-9.
45. Chen Z, Xu Z, Collins R, Li W, Peto R. Early health effect of the emerging tobacco epidemic in China. A 16-year prospective study. JAMA 1997;278:1500-4.
46. CDC. Annual smoking-attributable mortality, years of potential life lost, and economic costs-United States, 1995-1999. MMWR 2002;51:303-3.
47. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States. Data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Inter Med 2000;160:1683-9.
48. Donato F, Pasini GF, Buizza MA, Fantoni C, Tomasi E, Tani M, Grassi V. Tobacco smoking, occupational exposure and chronic respiratory disease in an Italian industrial area. Monaldi Arch Chest Dis 2000;55:194-200.
49. O'Connor GT, Sparrow D, Weiss ST. A prospective longitudinal study of methacoline airway responsiveness as a predictor of pulmonary function decline. The Normative Aging Study. Am J Respir Crit Care Med 1995;152:87-92.
50. Tashkin DP, Detels R, Simmons M, Liu H, Coulson AH, Sayre J, Rokaw S. The UCLA population studies of chronic obstructive respiratory disease. XI. Impact of air pollution and smoking on annual change in forced expiratory volume in one second. Am J Respir Crit Care Med 1994;149:1209-17.
51. US Surgeon General. The health consequence of smoking: chronic obstructive lung disease. Washington: US Department of Health and Human Service; 1984. (Publication No. 84-50205).
52. Viegi G, Di Pede C. Chronic obstructive lung disease and occupational exposure. Curr Opin Allergy Clin Immunol 2002;2:115-21.
53. Hnizdo E, Sullivan PA, Bang KM, Wagner G. Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2002;156:738-46.
54. Balmes J, Becklake M, Blanc P, Henneberger P, Kreiss K, Mapp C, Milton D, Schwartz D, Toren K, Viegi G. American Thoracic Society Statement. Occupational contribution to the burden of the airway disease. Am J Respir Crit Care Med 2003;167:787-97.
55. Chan-Yeung M, Dimich-Ward H. Natural history of occupational lung diseases. In: Occupational lung disorders. Mapp CE (Ed.). Eur Respir Mon 1999;4(11):46-63.
56. Newman Taylor AJ, Cullinan P. Diagnosis of occupational lung disease. In: Occupational lung disorders. Mapp CE (Ed.). Eur Respir Mon 1999;4(11):64-105.
57. De Raeve H, Nemery B. Lung diseases induced by metals and organic solvents. In: Occupational lung disorders. Mapp CE (Ed.). Eur Respir Mon 1999;4(11):178-213.
58. Burge PS. Occupational chronic obstructive pulmonary disease. In: Occupational lung disorders. Mapp CE (Ed.). Eur Respir Mon 1999;4(11):242-54.
59. Le Moual N, Bakke P, Kromhout H, Boezen HM, Vermeulen R, Orlowski E, Heederik D, Gulsvik A, Rijcken B, Kauffmann F. Relationship between occupational exposure, estimated by two job-exposure matrices, and lung function in French, Dutch, and Norwegian community studies. Eur Respir Rev 2001;11(80):91-7.
60. Coughlin SS, Chiazze L Jr. Job-exposure matrices in epidemiologic research and medical surveillance. Occup Med 1990;5:633-46.
61. Viegi G, Prediletto R, Paoletti P, Carrozzi L, Di Pede F, Vellutini M, Di Pede C, Giuntini C, Lebowitz MD. Respiratory effects of occupational exposure in a general population sample in north Italy. Am Rev Respir Dis 1991;143:510-5.
62. Zock JP, Sunjer J, Kogevinas M, Kromhout H, Burney P, Antò JM, and The ECRHS Study Group. Occupation, chronic bronchitis, and lung function in young adults. An international study. Am J Respir Crit Care Med 2001;163:1572-7.
63. 1 and subsequent respiratory symptoms, illnesses, and mortality in coal miners in the United States. Am J Respir Crit Care Med 2001;163:633-9.
64. 1 and airflow limitation related to occupational exposures in men of an urban community. Eur Respir J 1993;6:1095-103.
65. Committee of the Environmental an Occupational Health Assembly of the American Thoracic Society. Health effects of outdoor air pollution. Am J Respir Crit Care Med 1996;153:3-50.
66. American Thoracic Society. What constitutes an adverse health effect of air pollution? Am J Respir Crit Care Med 2000;161:665-73.
67. Viegi G, Baldacci S. Epidemiological studies of chronic respiratory conditions in relation to urban air pollution in adults. In: The impact of air pollution on respiratory health. D'Amato G, Holgate ST (Ed.). Eur Respir Mon 2002;7(21):1-16.
68. Baldacci S, Viegi G. Respiratory effects of environmental pollution: epidemiological data. Monaldi Arch Chest Dis 2002;57:156-60.
69. Brunekreef B, Holgate ST. Air pollution and health. Lancet 2002;360:1233-42.
70. Viegi G. Non-carcinogenic health effects of air pollution: a European perspective. Tubercle Lung Dis 1994;75:83-4.
71. Dockery DW, Pope CA 3rd. Acute respiratory effects of particulate air pollution. Annu Rev Public Health 1994;15:107-32.
72. Laden F, Neas LM, Dockery DW, Schwartz J. Association of fine particulate matter from different sources with daily mortality in six US cities. Environ Health Perspect 2000;108:941-7.
73. 2.5) and other air pollutants. J Exp Anal Environ Epidemiol 1995;5:137-59.
74. Künzli N, Kaiser R, Medina S, Studnicka M, Chanel O, Filliger P, Herry M, Horak F Jr, Puybonnieux-Texier V, Quenel P, Schneider J, Seethaler R, Vergnaud JC, Sommer H. Public-health impact of outdoor and traffic-related air pollution: a European assessment. Lancet 2000;356:795-801.
75. Ackermann-Liebrich U, Leuenberger P, Schwartz J, Schindler C, Monn C, Bolognini G, Bongard JP, Brandli O, Domenighetti G, Elsasser S, Grize L, Karrer W, Keller R, Keller-Wossidlo H, Kunzli N, Martin BW, Medici TC, Perruchoud AP, Schoni MH, Tschopp JM, Villiger B, Wuthrich B, Zellweger JP, Zemp E. Lung function and long term exposure to air pollutants in Switzerland. Study on Air Pollution and Lung Diseases in Adults (SAPALDIA) Team. Am J Respir Crit Care Med 1997;155:122-9.
76. Dockery DW, Pope CA 3rd, Xu X, Spengler JD, Ware JH, Fay ME, Ferris BG Jr, Speizer FE. An association between air pollution and mortality in six US Cities. N Engl J Med 1993;329:1753-9.
77. Pope CA 3rd, Thun MJ, Namboodiri MM, Dockery DW, Evans JS, Speizer FE, Heath CW Jr. Particulate air pollution as a predictor of mortality in a prospective study of US adults. Am J Respir Crit Care Med 1995;151:669-74.
78. Pope CA 3rd, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, Thurston GD. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 2002;287:1132-41.
79. Hoek G, Brunekreef, Goldbohm S, Fischer P, van den Brandt PA. Association between mortality and indicators of traffic-related air pollution in the Netherlands: a cohort study. Lancet 2002;360:1203-9.
80. Katsouyanni K, Touloumi G, Samoli E, Gryparis A, La Tertre A, Monopolis Y, Rossi G, Zmirou D, Ballester F, Boumghar A, Anderson HR, Wojtyniak B, Paldy A, Braunstein R, Pekkanen J, Schindler C, Schwartz J. Confounding and effect modification in the short term effects of ambient particles on total mortality: results from 29 European cities within the APHEA-2 project. Epidemiology 2001;12:521-3.
81. Simoni M, Biavati P, Carrozzi L, Viegi G, Paoletti P, Matteucci G, Ziliani GL, Ioannilli E, Sapigni T. The Po River Delta (North Italy) Indoor Epidemiological Study: home characteristics, indoor pollutants, and subjects' daily activity pattern. Indoor Air 1998;8:70-9.
82. 2.5 concentrations. J Air Waste Manag Assoc 2000;50:1157-66.
83. Samet JM, Marbury MC, Spengler JD. Health effects and sources of indoor air pollution. Part I. Am Rev Respir Dis 1987;136:1486-508.
84. Cook DG, Strachan DP, Carey IM. Health effects of passive smoking. 9. parental smoking and spirometric indices in children. Thorax 1998;53:884-93.
85. Venners SA, Wang X, Chen C, Wang B, Ni J, Jin Y, Yang J, Fang Z, Weiss ST, Xu X. Exposure-response relationship between paternal smoking and children's pulmonary function. Am J Respir Crit Care Med 2001;164:973-6.
86. Coultas DB. Health effects of passive smoking. 8. passive smoking and risk of adult asthma and COPD: an update. Thorax 1998;53:381-7.
87. Leuenberger P, Schwartz J, Ackermann-Liebrich U, Blaser K, Bolognini G, Bongard JP, Brandli O, Braun P, Bron C, Brutsche M, Domenighetti G, Elsasser S, Guldimann P, Hollestein C, Hufschmid P, Karrer W, Keller R, Keller-Wossidlo H, Kunzli N, Luthi JC, Martin BW, Medici T, Perruchoud AP, Radaelli A, Schindler C, Schoeni MH, Solari G, Tschopp JM, Villiger B, Wuthrich B, Zellweger JP, Zemp E. Passive smoking exposure in adults and chronic respiratory symptoms (SAPALDIA Study). Am J Respir Crit Care Med 1994;150:1222-8.
88. Baldacci S, Pistelli F, Di Pede F, Simoni M, Lo Presti E, Farchi S, Pistelli R, Corbo G, Forastiere F, Viegi G and the SEASD Group. Respiratory symptoms/diseases are related to environmental tobacco smoke (ETS) in an epidemiological study on environment and health in women from four Italian areas (SEASD). Eur Respir J 2001;18:274s.
89. Eisner MD. Environmental tobacco smoke esposure and pulmonary function among adults in NHANES III: impact on the general population and adults with asthma. Environ Health Perspect 2002;110:765-70.
90. Neas LM, Dockery DW, Ware JM, Spengler JD, Ferris BJ Jr, Speizer FE. Concentration of indoor particulate matter as a determinant of respiratory health in children. Am J Epidemiol 1994;139:1088-99.
91. Venners SA, Wang B, Ni J, Jin Y, Yang J, Fang Z, Xu X. Indoor air pollution and respiratory health in urban and rural China. Int J Occup Environ Health 2001;7:173-81.
92. Simoni M, Carrozzi L, Baldacci S, Scognamiglio A, Angino A, Pistelli F, Di Pede F, Viegi G. Acute respiratory effects of indoor pollutants in two general population samples living in a rural and in an urban area of Italy. In: Proceedings from 9th International Conference on Indoor Air Quality and Climate. Indoor Air 2002. Monterey, California (USA), June 30-July 5, 2002. vol. 1. p. 119-24.
93. Simoni M, Jaakkola MS, Carrozzi L, Baldacci S, Di Pede F, Viegi G. Indoor air pollution and respiratory health in the elderly. Eur Respir J 2003;21 (suppl. 40):15s-20s.
94. Garrett MH, Hooper MA, Hooper BM, Abramson MJ. Respiratory symptoms in children and indoor exposure to nitrogen dioxide and gas stoves. Am J Respir Crit Care Med 1998;158:891-5.
95. Jarvis D, Chinn S, Luczynska C, Burney P. Association of respiratory symptoms and lung function in young adults with use of domestic gas appliances. Lancet 1996;347:426-31.
96. Viegi G, Paoletti P, Carrozzi L, Vellutini M, Ballerin L, Biavati P, Nardini G, Di Pede F, Sapigni T, Lebowitz MD, Giuntini C. Effects of home environment on respiratory symptoms and lung function in a general population sample in North Italy. Eur Respir J 1991;4:580-6.
97. Krzyzanowski M, Quackenboss JJ, Lebowitz MD. Chronic respiratory effects of indoor formaldehyde exposure. Environ Res 1990;52:117-25.
98. Pappas GP, Herbert RJ, Henderson W, Koenig J, Stover B, Barnhart S. The respiratory effects of volatile organic compounds. Int J Occup Environ Health 2000;6:1-8.
99. Dales RE, Zwanemburg H, Burnett R, Franklin CA. Respiratory health effects of home dampness and molds among Canadian children. Am J Epidemiol 1991;134:196-203.
100. Murray CS, Woodcock A, Custovic A. Lifestyle and indoor air pollution: allergens. In: "The impact of air pollution on respiratory health". D'Amato G, Holgate ST (Ed.). Eur Respir Mon 2002;7 (21):133-52.
101. Viegi G, Carrozzi L, Pistelli F, Scognamiglio A, Baldacci S. Prevalenza e fattori di rischio acquisiti delle BPCO. In: Il volto della BPCO che cambia. vol 1. Giuntini C, Grassi G (Ed.). Torino: UTET; 2001. p. 49-66.
102. Viegi G, Carrozzi L, Di Pede F, Baldacci S, Pedreschi M, Modena P, Paoletti P. Risk factors for chronic obstructive pulmonary disease in a North Italian rural area. Eur J Epidemiol 1994;10:725-31.
103. Prescott E, Godtfredsen N, Vestbo J, Osler M. Social position and mortality from respiratory diseases in males and females. Eur Respir J 2003;21:821-6.
104. Romieu I, Trenga C. Diet and obstructive lung diseases. Epidemiol Rev 2001;23:268-87.
105. Watson L, Margetts B, Howarth P, Dorward M, Thompson R, Little P. The association between diet and chronic obstructive pulmonary disease in subjects selected from general practice. Eur Respir J 2002;20:313-8.
106. Tabak C, Arts IC, Smit HA, Heederik D, Kromhout D. Chronic obstructive pulmonary disease and intake of catechins, flavonols, and flavones: the MORGEN Study. Am J Respir Crit Care Med 2001;164:61-4.
107. Tabak C, Smit HA, Heederik D, Ocke MC, Krombout D. Diet and chronic obstructive pulmonary disease: independent beneficial effects of fruits, whole grains, and alcohol (the MORGEN study). Clin Exp Allergy 2001;31:747-55.
108. Walda IC, Tabak C, Smit HA, Rasanen L, Fidanza F, Menotti A, Nissinen A, Feskens EJ, Kromhout D. Diet and 20-year chronic obstructive pulmonary disease mortality in middle-aged men from three European countries. Eur J Clin Nutr 2002;56:638-43.
109. Sherrill DL, Lebowitz MD, Burrows B. Epidemiology of chronic obstructive pulmonary disease. Clin Chest Med 1990;11:375-87.
110. Barnes PJ. Molecular genetics of chronic obstructive pulmonary disease. Thorax 1999;54:245-52.
111. Sandford AJ, Silverman EK. Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction. Thorax 2002;57:736-41.
112. 1-antitrypsin gene and the risk of chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 1999;20:287-91.
113. Silverman EK. Genetic epidemiology of COPD. Chest 2002;121:1s-6s.
114. Turino GM, Barker AF, Brantly ML, Cohen AB, Connelly RP, Crystal RG, Eden E, Schluchter MD, Stoller JK. Clinical features of individuals with PI*SZ phenotype of α-1-antitrypsin deficiency. Alpha-1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med 1996;154:1718-25.
115. Churg A, Dai J, Tai H, Xie C, Wright JL. Tumor necrosis factor-alpha is central to acute cigarette smoke-induced inflammation and connective tissue breakdown. Am J Respir Crit Care Med 2002;166:849-54.
116. Joost O, Wilk JB, Cupples A, Harmon M, Shearman AM, Baldwin CT, O'Connor GT, Myers RH, Gottlieb DJ. Genetic loci influencing lung function. A genomewide scan in the Framingham study. Am J Respir Crit Care Med 2002;165:795-9.
117. Silverman EK, Weiss ST, Drazen JM, Chapman HA, Carey V, Campbell EJ, Denish P, Silverman RA, Celedon JC, Reilly JJ, Ginns LC, Speizer FE. Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;162:2152-8.
118. Nilsson S, Carstensen JM, Pershagen G. Mortality among male and female smokers in Sweden: a 33 year follow-up. J Epidemiol Community Health 2001;55:825-30.
119. Hogg JC. Childhood viral infection and the pathogenesis of asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 1999;160:26s-8s.
120. Sethi S. Bacterial infection and the pathogenesis of COPD. Chest 2000;117:286s-91s.
121. 1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:1090-5.
122. Shaheen SO, Barker DJ, Shiell AW, Crocker FJ, Wield GA, Holgate ST. The relationship between pneumonia in early childhood and impaired lung function in late adult life. Am J Respir Crit Care Med 1994;149:616-9.
123. Shaheen SO, Barker DJ, Holgate ST. Do lower respiratory tract infections in early childhood cause chronic obstructive pulmonary disease? Am J Respir Crit Care Med 1995;151:1649-51.
124. Johnston ID, Strachan DP, Anderson HR. Effect of pneumonia and whooping cough in childhood on adult lung function. N Engl J Med 1998;338:581-7.
125. Carrozzi L, Paoletti P, Prediletto R, Carmignani G, Viegi G, Di Pede F, Mammini U, Giuntini C. Malattie respiratorie dell'infanzia e predisposizione familiare per malattie dell'apparato respiratorio. Medicina Toracica 1988;10:257-62.
126. Stick SM, Burton PR, Gurrin L, Sly PD, Le Souef PN. Effects of maternal smoking during pregnancy and a family history of asthma on respiratory function in new-born infants. Lancet 1996;348:1060-4.
127. Carrozzi L, Rijcken B, Burney P, DeGraaf A, Angino A, Di Pede F, Pistelli F, Viegi G, Giuntini C. Family history for chronic lung diseases and epidemiological determinants of COPD in three European countries. Eur Respir Rev 2001;11(80):49-54.
128. Lu B, He Q, Chen Q, Huang X, Li j. Pulmonary function in first generation children of chronic obstructive pulmonary disease (COPD) patients: assessment of related predicting factors. Zhonghua Yi Xue Za Zhi 2002;82:1136-9.
129. McCloskey SC, Patel BD, Hinchliffe SJ, Reid ED, Wareham NJ, Lomas DA. Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. Am J Respir Crit Care Med 2001;164:1419-24.
130. Cheng X, Wu Y, Li J. Study on susceptibility risk factors for COPD in smokers. Zhonghua Jie He He Hu Xi Za Zhi 1999;22:602-4.
131. Guerra S, Sherrill DL, Bobadilla A, Martinez FD, Barbee RA. The relation of body mass index to asthma, chronic bronchitis, and emphysema. Chest 2002;122:1256-63.
132. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest 2000;117:5-9.
133. Strassels SA. Economic consequences of chronic obstructive pulmonary disease. Curr Opin Pulm Med 1999;5:100-4.
134. National Hearth, Lung and Blood Institute. Chronic obstructive pulmonary disease (COPD). Data Fact Sheet 2001;1-4.
135. Rutten-van Molken MP, Postma MJ, Joore MA, Van Genugten ML, Leidl R, Jager JC. Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands. Respir Med 1999;93:779-87.
136. Jansson SA, Andersson F, Borg S, Ericson A, Jonsson E, Lundback B. Costs of COPD in Sweden according to disease severity. Chest 2002;122:1994-2002.
137. Dal Negro R, Rossi A, Cerveri I. The burden of COPD in Italy: results from the Confronting COPD survey. Respir Med 2003;97:43s-50s.